• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

biopharma industry

India India pharma Indian pharmaceutical industry rupee pills
Favicon Fierce Biotech

How India can build on its budding innovative R&D moment: report

A string of recent wins on the frontiers of novel drug development could mean that a homegrown innovation industry is within reach.
Fraiser Kansteiner Jul 23, 2026 5:00am
Pharma money pharma money pharma profits Big Pharma sales drug sales

Obesity meds, China drive $2T in projected 2032 drug sales: report

Jun 23, 2026 9:00am
Graphic images of red and white pill capsules lined up diagonally in front of a yellow background

US healthcare, life sci could benefit from disruption: poll

May 27, 2026 8:00am
fourth quarter Q4

Lilly shines in Q4 as peers brace for 2026 slowdown

Mar 11, 2026 3:00pm
US Sen Ron Wyden D-OR speaks to press in the US Capitol on February 03 2025 in Washington DC

7 Democrats press pharmas for details on Trump MFN agreements

Mar 6, 2026 2:52pm
pause button on blue background

EU pumps brakes on US trade deal after Trump's tariff blow

Feb 23, 2026 3:04pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings